Shopping Cart
Remove All
Your shopping cart is currently empty
EGFR/HER2-IN-13 (Compd 38) serves as an inhibitor targeting mutant EGFR/HER2s that show resistance to existing drugs. It is primarily utilized in cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,180 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,800 | 8-10 weeks | 8-10 weeks |
| Description | EGFR/HER2-IN-13 (Compd 38) serves as an inhibitor targeting mutant EGFR/HER2s that show resistance to existing drugs. It is primarily utilized in cancer research. |
| In vitro | EGFR/HER2-IN-13 exhibits an IC50 of less than 100 nM in Ba/F3 cells transfected with mutated EGFR variants insASV, insSVD, and insGSP [1]. |
| Molecular Weight | 520.63 |
| Formula | C27H36N8O3 |
| Cas No. | 3034701-46-4 |
| Smiles | O=C(C=C)NC1=CC(NC2=NC=C3C(=N2)N(C(=O)N(C3)C45CC(C4)C5)C)=C(OC)C=C1N(C)CCN(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.